INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/06/2022
Back to search
Official data from USPTO
GLYCOEXPRESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLYCOEXPRESS
ST13
US500000079068784Class
1, 5, 42
Filing
79068784
Registration
3991708
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
71
Latest update
11/06/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/27/2008
Registration date
07/12/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2022
Last transaction
01/28/2022
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
13125 Berlin, DE
Examiner
LEE, DEBRA ANN
Law office
M70
Holders and representatives
Holders
Glycotope GmbH
Glycotope GmbH
Representatives
GARY D. KRUGMAN SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizing preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elementsfragmentsfractions and lysates thereofexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatmentbacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cellsexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatment; biological preparations for laboratoriesexcept for medical or veterinary purposesfor use in bacterial and cell engineeringcultivationharvestingprotein production; chemical preparations for analysis in laboratoriespreparations for proteinpeptideengineered proteins and peptidesglycoproteinsglycosylationantibody or antigen analysispreparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein productionbacterial and cell engineeringcultivation and harvestingprobes for detecting and analyzing molecules in protein or nucleotide arraysexcept for medical or veterinary purposes; diagnostic preparationsexcept for medical or veterinary purposes; enzymesproteins and respective preparations for industrial purposesengineered proteinsglycosylated proteinsantibodiesenzymes for use in glycosylationenzyme substratesproteins used in the manufacture of cosmeticsbeveragesfood products and food supplements; ferments for chemical purposesyeastbacteriummoldenzymethat causes fermentation; in-vitro diagnostic preparationsother than for medical purposes; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms and cells and elementsfragmentsfractions and lysates thereofother than for medical or veterinary purposescultures of microorganisms and cells other than for medical and veterinary usemicroorganism or cell cultures for use in protein productionfood manufacturingscientific researchwaste water treatmentcultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; gene expression systems for proteins and peptidesparticularly on the basis of cellsparticularly human cells and microorganismsgene expression systems comprising biochemicalsassaysreagents for use in manufacturing engineered or glycosylated proteins or peptides and for scientific researchgene expression systems comprising biochemicalsassays and reagents with optimized glycosylation activity for use in manufacturing proteins or peptidesin particular engineered or glycosylated proteins or peptidesfor scientific research; milk ferments for medical research purposes
Class 5
Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; disinfectants for sanitary purposes; preparations for destroying vermin; fungicidesherbicides; adjuvants for medical purposes; medicines for human and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymeproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicineas nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; microorganismscells and preparations containing elementsfragmentsfractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological therapeuticstherapeutics containing cellsmicroorganismsproteinsglycoproteinspeptidesglycopeptides or modified or conjugated versions thereof for use in the prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes for human or animalsnutritional additives in the nature of enzymesproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof; sugar and carbohydrates for medical purposestherapeutically and prophylactically active sugar and carbohydratesdietetic sugar and carbohydratessugar and carbohydrate replacements
Class 42
Scientific and technological servicesbacteria and cell engineering servicesbacteria and cell cultivation and harvesting servicesresearch and development related to protein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and design services in the field of biotechnologyprotein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; industrial analysis and research services in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveysconducting biotechnology surveyspharmacology surveys; conducting scientific surveys in the field of biotechnologybacterial and cell engineeringprotein productionglycosylation; research and development in the field of bacteriologycytologyantibody technologychemistryimmunologycosmetics of expression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesparticularly for proteins and peptides; quality control; research and development of new products and technologies in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting for others; technology and scientific consultancy in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and development in the field of glycomicsexpression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesdevelopment and improvement of cellscell lines and microorganismsantibody-engineeringoptimized biological therapeutics; nutraceuticalsfood and nutritional supplements; researchquality controltechnology consultancy and product development in the field of proteinsantibodiesmicroorganisms and cells; research and development in the field of microorganisms and cells
Publications
History of USPTO decisions and trademark events.
71 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/06/2022
INPC
INVALIDATION PROCESSED
10/06/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/28/2022
C71T
CANCELLED SECTION 71
01/28/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/27/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/19/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/13/2018
INPC
INVALIDATION PROCESSED
09/13/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/03/2018
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
07/27/2017
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
07/27/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/22/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
07/06/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/14/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/03/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/06/2012
FIMP
FINAL DISPOSITION PROCESSED
01/05/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/12/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2011
PUBO
PUBLISHED FOR OPPOSITION
04/26/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/23/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/06/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/06/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/22/2011
EXPT
EXPARTE APPEAL TERMINATED
03/22/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/21/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
03/21/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2011
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
03/11/2011
GECD
ACTION DENYING REQ FOR RECON E-MAILED
03/11/2011
CNCF
ACTION CONTINUING FINAL - COMPLETED
03/11/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/05/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/17/2011
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/17/2011
EXPI
EX PARTE APPEAL-INSTITUTED
02/14/2011
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/14/2011
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
02/14/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2011
ALIE
ASSIGNED TO LIE
01/31/2011
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/31/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2010
CNFR
FINAL REFUSAL MAILED
08/12/2010
CNFR
FINAL REFUSAL WRITTEN
08/11/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/27/2010
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/21/2010
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/21/2010
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
01/05/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2009
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/30/2009
ATRV
ATTORNEY REVIEW COMPLETED
10/17/2009
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
09/25/2009
RFNP
REFUSAL PROCESSED BY IB
09/19/2009
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/18/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/26/2009
RFRR
REFUSAL PROCESSED BY MPU
06/26/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/26/2009
CNRT
NON-FINAL ACTION WRITTEN
06/25/2009
MAFR
APPLICATION FILING RECEIPT MAILED
06/23/2009
DOCK
ASSIGNED TO EXAMINER
06/19/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/19/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/18/2009
Continuous trademark protection
Get notified about every new filing that threatens GLYCOEXPRESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.